Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 4;108(2):420–432. doi: 10.3324/haematol.2022.281585

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2023 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 3. — Post-hematopoietic cell transplantation (HCT) outcomes for 506 adults with acute myeloid leukemia and initial abnormal cytogenetics undergoing allogeneic HCT while in first or second morphologic remission, stratified by both pre-HCT cytogenetics and multiparameter flow cytometry and conditioning intensity. (A) Cumulative incidence of relapse and (B) overall survival for patients receiving myeloablative conditioning (MAC) and (C) cumulative incidence of relapse and (D) overall survival for patients receiving non-MAC, respectively. Cyto N: normal cytogenetics; Cyto AbN: abnormal cytogenetics; MFC: multiparameter flow cytometry.